Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01D OTHER BETA-LACTAM ANTIBACTERIALS
J01DD Third-generation cephalosporins
J01DD52 Ceftazidime and beta-lactamase inhibitor
D10779 Ceftazidime and avibactam <US>
USP drug classification [BR:br08302]
Antibacterials
Beta-lactam, Cephalosporins
Avibactam Sodium/ Ceftazidime
D10779 Ceftazidime and avibactam
Antimicrobials [BR:br08307]
Antibacterials
Cell wall biosynthesis inhibitor, beta-lactam
Third-generation cephalosporin
D10779 Ceftazidime and avibactam <US>
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Cell wall biosynthesis inhibitor, beta-lactam
Third-generation cephalosporin
D10779 Ceftazidime and avibactam
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10779
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10779
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10779
